Shares of Nanalysis Scientific Corp. (CVE:NSCI – Get Free Report) traded down 12.1% on Monday . The stock traded as low as C$0.15 and last traded at C$0.15. 274,264 shares changed hands during mid-day trading, an increase of 203% from the average session volume of 90,466 shares. The stock had previously closed at C$0.17.
Nanalysis Scientific Stock Performance
The company has a debt-to-equity ratio of 71.72, a current ratio of 1.42 and a quick ratio of 1.11. The stock has a market cap of C$17.22 million, a PE ratio of -1.50 and a beta of -0.91. The business has a 50 day moving average price of C$0.18 and a two-hundred day moving average price of C$0.22.
Nanalysis Scientific Company Profile
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.
Read More
- Five stocks we like better than Nanalysis Scientific
- What is a Microcap Stock? Everything You Need to Know
- 5 Tech Stocks Insiders Are Selling (But Smart Investors Are Loading Up)
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Why FuelCell Energy Stock Is Soaring After a Government Deal
- What is the Hang Seng index?
- SoftBank’s Next AI Move? DigitalBridge Rockets 46% on Takeover Buzz
Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
